Particularitățile hormonului anti-Mullerian în determinarea rezervei ovariene

Abstract

The problem addressed in this article is the appreciation of the anti-Mullerian hormone as a factor not only in estimating the number of oocytes obtained in FIV programs but also in their quality. It has been shown that patients with high levels of AMH are more likely to get good quality oocytes than those with low levels of this hormone.